Less Noise, More Value: From Identifying Critical to Quality Data to Prioritising It

About this session

The presentation includes highlights from one of AstraZeneca’s global projects, which embeds risk-based thinking into clinical trial planning and execution. It goes beyond trial monitoring, focusing rather on revision of end-to-end ways of working through clinical trial execution. The initiative aimed to improve data quality, but also operational efficiency. The presentation will cover aspects considered key for its delivery, lessons learnt, and hints on metrics defined to measure project impact.

Speaker

• TZ

  Tomasz Zawadzki

  Director, Centralized Monitoring · AstraZeneca

  Speaker